Extensively reviewed evidence has associated Nrg4 with protective effects against metabolic dysregulation in various metabolic diseases, such as insulin resistance, obesity, NAFLD, and diabetes mellitus through several mechanisms, such as anti-inflammation, autophagy regulation, pro-angiogenesis, and substrate metabolism [35,36]. The gene discussed is NRG4; the disease is metabolic dysfunction-associated steatotic liver disease.